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HISTOCHEMICAL DEMONSTRATION OF MONOAMINE OXIDASE IN
HUMAN SKIN*
WALTER B. SHELLEY, M.D., PH.D., SHELBY BRENNER COHEN, B.S. AND
GEORGE B. KOELLE, M.D., PH.D.
In an excellent review of the enzymes in skin, Lerner (1) has recently pointed
out that these protein metabolic catalysts fall into two groups: (A) enzymes
affecting energy release from carbohydrates, fats and protein, and (B) enzymes
concerned with specialized activities. Monoamine oxidase (MAO), the subject
of this communication, is an enzyme which comes under the second group. It
oxidizes mono-amines [primary (R-NH2), secondary (R2NH), or tertiary (R3N)]
to the corresponding aldehydes, but does not affect diamines such as histamine.
Monoamine oxidase was first discovered in 1928 in liver (2). Here it was
postulated to play an important role in the oxidative detoxification of amines
produced in the intestine by the bacterial decarboxylation of certain amino acids.
It has subsequently been shown to occur in many other tissues, including the
brain, kidney, uterus, placenta, thyroid, and smooth muscles (3). In addition,
it is found in plants, e.g., in Salvia, where it appears to be concerned with alkaloid
synthesis. Its concentration can be determined in tissue homogenates or acetone
powers by using tyramine as a substrate and measuring either NH3-formation or
Os-uptake. More recently, histochemical procedures have been developed for
localizing its presence in tissue sections (4, 5). Monoamine oxidase has never been
purified sufficiently to permit its chemical characterization. It apparently is a
constituent of the cell mitochondria and does not appear in the nuclei. It is in-
hibited by antihistaminics, local anesthetics, amphetamine, ephedrine and
imidazolines, whereas atropine, carbon monoxide and cyanide are without
effect (3, 6).
Physiologically, the role of MAO is still to be defined in detail. In addition to
oxidative detoxification of amines in the liver, it has been considered to take part
in the metabolism of the naturally occurring sympathomimetic amines: epi-
nephrine, norepinephrine and 5-OH-tryptamine (3, 7).
The present study was undertaken to determine the histochemical localization
of MAO in normal human skin. Using another recent histochemical method (4),
Hellmann (8) found evidence of high MAO activity in the sweat glands of the
horse, low activity in the cat, but none in the glands of human skin.
METHOD
Five axillary biopsies were taken from normal healthy young male adults.
Three were taken from areas which had been locally anesthetized with procaine,
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and two from unanesthetized skin. The latter was achieved using a high speed
rotary punch (9). The specimens were immediately placed on ice or dry ice, and
kept frozen until sectioning. The histochemical technic employed was the one
recently devised by Koelle and Valk (5). Fresh frozen sections were incubated at
370 C for 2 hours in an oxygenated medium containing tryptamine, 2-011-3-
naphthoic acid hydrazine, Na2SO4, and phosphate buffer. The condensation
product of the hydrazine with the aldehyde resulting from the action of the
MAO on tryptamine was coupled with tetrazotized o-dianisidine, forming a deep
purple precipitate. Controls to distinguish non-enzymatic staining artifacts were
obtained by (1) selective inhibition of the enzyme by exposure to 1-isonicotinyl-
2-isopropyihydrazine, and (2) incubation in the absence of the substrate (tryp-
tamine). Details of the method are given in the original paper (5). Any staining in
either type of control slide was considered to be an artifact, and the corresponding
areas were discounted in evaluating the distribution of the enzyme.
RESULTS
The most intense staining for MAO activity was seen in the sweat glands.
In the eccrine glands, the tubules revealed heavy punctate purplish deposits
which readily distinguished them from the ducts, which showed diffuse light
staining. The apocrine sweat glands showed similar evidence of MAO activity.
Here the secretory cells showed numerous pigmented granules. The myoepithe-
hum did not stain. The sebaceous glands also revealed the presence of appreci-
able amounts of MAO. (Figures 1—4).
FIG. 1. MAO stain: Ducts and secretory coils of eccrine sweat glands. X160
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Fin. 2. MAO stain: Apocrine sweat gland secretory tubules. X160
FIG. 3. MAO stain: Secretory coil and ducts of eccrine sweat gland. This high power
view shows dark granular deposits of pigment in the secretory cells in striking contrast to
the diffuse staining of the ductal cells. X500
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Fiu. 4. MAO stain: Secretory cells of apocrinc sweat gland acinus. Note granular pig-
ment aad also abseace of stain in nuclei and myoepithelium. Some of the larger granules
were also seen in control specimens, and represent normal pigment of apocrine secretory
cells. X500
The epidermal cells showed faint diffuse staining. The keratin, however, was
not stained nor did the melanocytes show any darkening. The wall of the hair
follicle shared in the faint epidermal staining. The collagen was not stained and it
appeared probable that elastic fibers had but little, if any, color. Arrectores
pilorum showed slight staining. No nerve tissue could be visualized as having
been stained by the reaction.
DISCUSSION
These observations indicate the wide-spread occurrence of yet another enzyme
in the skin. Monoamine oxidase appears to be associated chiefly with the epi-
dermal cells and their derivatives, sebaceous and sweat glands. In the secretory
cells of the sweat glands the enzyme appeared in granular form, which in the
eccrine gland may represent the mitochondria. Interestingly, this enzyme may be
partly responsible for the ammonia which appears in eccrine sweat since it is
liberated by oxidative deamination of primary amines. It is also possible to
speculate that this enzyme may be related to the appearance of colored apocrine
sweat, i.e. chromidrosis. The oxidation of tryptamine or 5-Oll-tryptamiue, can
lead to the formation of a dark pigment (4). Thus, in the presence of tryptamine,
or other chromogenic amines, the apocrine secretory cells may form such a pig-
ment which then could color the small volume of apocrine sweat produced. In the
eccrine gland a similar pigment formation might also take place, but no color
would be expected because of the factor of dilution.
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Initially it was hoped that localization of MAO activity might providc a means
of distinguishing adrenergic from cholinergic nerve fibers. In the rabbit, evidence
was found of its selective localization in the former but this distinction did not
hold in the cat (5). In the present work, however, we were unable to identify any
staining of nerve tissue. No nerve fibrillae were seen around either the eccrine or
apocrine gland. Presumably, the level of activity in nerves of human skin is
below the limit of sensitivity of the method.
Despite the use of procaine in the biopsy procedure, no evidence of enzyme
inhibition could be seen. It is likely that the anesthetic was washed out of the
slides by pretreatment rinses.
CONCLUSION
Monoamine oxidase has been shown histochemically to exist in normal
human skin. It was found in the epidermis, sebaceous gland, eccrine and apocrine
glands.
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